医療用メタゲノムの世界市場:規模・現状・予測2019-2025

【英語タイトル】Global Metagenomics in Healthcare Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR20FB05599)・商品コード:QYR20FB05599
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:97
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、医療用メタゲノムの世界市場について調査・分析し、医療用メタゲノムの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(サンプル抽出キット、メタゲノムキット)、用途別(製薬産業、バイオテクノロジー企業、病理学研究所、学術研究所、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の医療用メタゲノム市場動向
・主要企業別マーケットシェア
・医療用メタゲノムの種類別市場規模2014-2019
(サンプル抽出キット、メタゲノムキット)
・医療用メタゲノムの用途別市場規模2014-2019
(製薬産業、バイオテクノロジー企業、病理学研究所、学術研究所、その他)
・医療用メタゲノムの北米市場:主要企業・種類別/用途別市場規模
・医療用メタゲノムのヨーロッパ市場:主要企業・種類別/用途別市場規模
・医療用メタゲノムの中国市場:主要企業・種類別/用途別市場規模
・医療用メタゲノムの日本国内市場:主要企業・種類別/用途別市場規模
・医療用メタゲノムの東南アジア市場:主要企業・種類別/用途別市場規模
・医療用メタゲノムのインド市場:主要企業・種類別/用途別市場規模
・医療用メタゲノムの中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Illumina、QIAGEN、PerkinElmer、Thermo Fisher Scientific、Oxford Nanopore Technologies)
・医療用メタゲノムの市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Metagenomics is the study of genetic material recovered directly from environmental samples.In 2018, the global Metagenomics in Healthcare market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Metagenomics in Healthcare status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metagenomics in Healthcare development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies

Market segment by Type, the product can be split into
Sample Extraction Kits
Metagenomics Kits

Market segment by Application, split into
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metagenomics in Healthcare status, future forecast, growth opportunity, key market and key players.
To present the Metagenomics in Healthcare development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metagenomics in Healthcare are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metagenomics in Healthcare Market Size Growth Rate by Type (2014-2025)
1.4.2 Sample Extraction Kits
1.4.3 Metagenomics Kits
1.5 Market by Application
1.5.1 Global Metagenomics in Healthcare Market Share by Application (2019-2025)
1.5.2 Pharmaceutical Industries
1.5.3 Biotechnology Companies
1.5.4 Pathology Laboratories
1.5.5 Academic and Research Laboratories
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Metagenomics in Healthcare Market Size
2.2 Metagenomics in Healthcare Growth Trends by Regions
2.2.1 Metagenomics in Healthcare Market Size by Regions (2019-2025)
2.2.2 Metagenomics in Healthcare Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Metagenomics in Healthcare Market Size by by Players
3.1.1 Global Metagenomics in Healthcare Revenue by by Players (2014-2019)
3.1.2 Global Metagenomics in Healthcare Revenue Market Share by by Players (2014-2019)
3.1.3 Global Metagenomics in Healthcare Market Concentration Ratio (CR5 and HHI)
3.2 Metagenomics in Healthcare Key Players Head office and Area Served
3.3 Key Players Metagenomics in Healthcare Product/Solution/Service
3.4 Date of Enter into Metagenomics in Healthcare Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Metagenomics in Healthcare Market Size by Type (2014-2019)
4.2 Global Metagenomics in Healthcare Market Size by Application (2014-2019)

5 North America
5.1 North America Metagenomics in Healthcare Market Size (2014-2019)
5.2 Metagenomics in Healthcare Key Players in North America
5.3 North America Metagenomics in Healthcare Market Size by Type
5.4 North America Metagenomics in Healthcare Market Size by Application

6 Europe
6.1 Europe Metagenomics in Healthcare Market Size (2014-2019)
6.2 Metagenomics in Healthcare Key Players in Europe
6.3 Europe Metagenomics in Healthcare Market Size by Type
6.4 Europe Metagenomics in Healthcare Market Size by Application

7 China
7.1 China Metagenomics in Healthcare Market Size (2014-2019)
7.2 Metagenomics in Healthcare Key Players in China
7.3 China Metagenomics in Healthcare Market Size by Type
7.4 China Metagenomics in Healthcare Market Size by Application

8 Japan
8.1 Japan Metagenomics in Healthcare Market Size (2014-2019)
8.2 Metagenomics in Healthcare Key Players in Japan
8.3 Japan Metagenomics in Healthcare Market Size by Type
8.4 Japan Metagenomics in Healthcare Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Metagenomics in Healthcare Market Size (2014-2019)
9.2 Metagenomics in Healthcare Key Players in Southeast Asia
9.3 Southeast Asia Metagenomics in Healthcare Market Size by Type
9.4 Southeast Asia Metagenomics in Healthcare Market Size by Application

10 India
10.1 India Metagenomics in Healthcare Market Size (2014-2019)
10.2 Metagenomics in Healthcare Key Players in India
10.3 India Metagenomics in Healthcare Market Size by Type
10.4 India Metagenomics in Healthcare Market Size by Application

11 Central & South America
11.1 Central & South America Metagenomics in Healthcare Market Size (2014-2019)
11.2 Metagenomics in Healthcare Key Players in Central & South America
11.3 Central & South America Metagenomics in Healthcare Market Size by Type
11.4 Central & South America Metagenomics in Healthcare Market Size by Application

12 International Players Profiles
12.1 Illumina
12.1.1 Illumina Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metagenomics in Healthcare Introduction
12.1.4 Illumina Revenue in Metagenomics in Healthcare Business (2014-2019))
12.1.5 Illumina Recent Development
12.2 QIAGEN
12.2.1 QIAGEN Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metagenomics in Healthcare Introduction
12.2.4 QIAGEN Revenue in Metagenomics in Healthcare Business (2014-2019)
12.2.5 QIAGEN Recent Development
12.3 PerkinElmer
12.3.1 PerkinElmer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metagenomics in Healthcare Introduction
12.3.4 PerkinElmer Revenue in Metagenomics in Healthcare Business (2014-2019)
12.3.5 PerkinElmer Recent Development
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metagenomics in Healthcare Introduction
12.4.4 Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2014-2019)
12.4.5 Thermo Fisher Scientific Recent Development
12.5 Oxford Nanopore Technologies
12.5.1 Oxford Nanopore Technologies Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metagenomics in Healthcare Introduction
12.5.4 Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2014-2019)
12.5.5 Oxford Nanopore Technologies Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details



【掲載企業】

Illumina、QIAGEN、PerkinElmer、Thermo Fisher Scientific、Oxford Nanopore Technologies

★調査レポート[医療用メタゲノムの世界市場:規模・現状・予測2019-2025] (コード:QYR20FB05599)販売に関する免責事項を必ずご確認ください。
★調査レポート[医療用メタゲノムの世界市場:規模・現状・予測2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆